Biblio

] Title Type Year

Filters: First Letter Of Last Name is K [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

K

Komarow HD, Brenchley JM, A Eisch R, Young ML, Scott LM, Kulinski JM, Heller T, Bai Y, Metcalfe DD. A study of microbial translocation markers in mastocytosis. Clin Exp Allergy. 2020.

Komarova NL. Principles of regulation of self-renewing cell lineages. PLoS One. 2013;8(9):e72847.

Komae H, Ono M, Shimizu T. Cell Sheet-Based Vascularized Myocardial Tissue Fabrication. Eur Surg Res. 2018;59(3-4):276-285.

Komada M, Nagao T, Kagawa N. Postnatal di-2-ethylhexyl phthalate exposure affects hippocampal dentate gyrus morphogenesis. J Appl Toxicol. 2020.

Komabayashi-Suzuki M, Yamanishi E, Watanabe C, Okamura M, Tabata H, Iwai R, Ajioka I, Matsushita J, Kidoya H, Takakura N, et al. Spatiotemporally Dependent Vascularization Is Differently Utilized among Neural Progenitor Subtypes during Neocortical Development. Cell Rep. 2019;29(5):1113-1129.e5.

Kolybaba A, Classen A-K. Sensing cellular states-signaling to chromatin pathways targeting Polycomb and Trithorax group function. Cell Tissue Res. 2014.

Kolundzic N, Khurana P, Devito L, Donne M, Hobbs C, Jeriha J, Wong XFei Colin, Common JAE, Lane EBirgitte, Dubrac S, et al. Induced pluripotent stem cell line heterozygous for p.R2447X mutation in filaggrin: KCLi002-A. Stem Cell Res. 2019;38:101462.

Kolundzic N, Khurana P, Hobbs C, Rogar M, Ropret S, Törmä H, Ilic D, Liovic M. Induced pluripotent stem cell (iPSC) line from an epidermolysis bullosa simplex patient heterozygous for keratin 5 E475G mutation and with the Dowling Meara phenotype. Stem Cell Res. 2019;37:101424.

Kolundzic N, Khurana P, Devito L, Jeriha J, Marx J, Hobbs C, Wong XFei Colin, Common JEA, Liovic M, Dubrac S, et al. Induced pluripotent stem cell line heterozygous for p.R501X mutation in filaggrin: KCLi003-A. Stem Cell Res. 2019;39:101527.

Kolstad A, Laurell A, Jerkeman M, Grønbæk K, Elonen E, Räty R, Pedersen LBredo, Loft A, Bogsrud TVelde, Kimby E, et al. Nordic MCL-3 study: BEAM/C conditioning intensified with 90Y-Ibritumomab-Tiuxetan in responding non-CR patients followed by autologous transplant in mantle cell lymphoma. Blood. 2014.

Kolosnjaj-Tabi J, Gibot L, Fourquaux I, Golzio M, Rols M-P. Electric field-responsive nanoparticles and electric fields: Physical, chemical, biological mechanisms and therapeutic prospects. Adv Drug Deliv Rev. 2018.

Kolonin MG. How brown is brown fat that we can see?. Adipocyte. 2014;3(2):155-9.

Kolodziejczyk AA, Kim JKyoung, Tsang JCH, Ilicic T, Henriksson J, Natarajan KN, Tuck AC, Gao X, Bühler M, Liu P, et al. Single Cell RNA-Sequencing of Pluripotent States Unlocks Modular Transcriptional Variation. Cell Stem Cell. 2015;17(4):471-485.

Kolodziejczak AS, Guerrini-Rousseau L, Planchon JMasliah, Ecker J, Selt F, Mynarek M, Obrecht D, Sill M, Autry RJ, Zhao E, et al. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome. Neuro Oncol. 2023.

Kolodin D, van Panhuys N, Li C, Magnuson AM, Cipolletta D, Miller CM, Wagers A, Germain RN, Benoist C, Mathis D. Antigen- and Cytokine-Driven Accumulation of Regulatory T Cells in Visceral Adipose Tissue of Lean Mice. Cell Metab. 2015;21(4):543-557.

Kolls BJ, Muir KW, Savitz SI, Wechsler LR, Pilitsis JG, Rahimi S, Beckman RL, Holmes V, Chen PR, Albers DS, et al. Experience with a hybrid recruitment approach of patient-facing web portal screening and subsequent phone and medical record review for a neurosurgical intervention trial for chronic ischemic stroke disability (PISCES III). Trials. 2024;25(1):150.

Kollmann S, Grausenburger R, Klampfl T, Prchal-Murphy M, Bastl K, Pisa H, Knab VMaria, Brandstoetter T, Doma E, Sperr WR, et al. A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells. Blood. 2021.

Kolliopoulos C, Lin C-Y, Heldin C-H, Moustakas A, Heldin P. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer. Matrix Biol. 2018.

Kolliopoulos V, Polanek M, Xu H, Harley B. Inflammatory Licensed hMSCs Exhibit Enhanced Immunomodulatory Capacity in a Biomaterial Mediated Manner. ACS Biomater Sci Eng. 2023.

Kolliopoulos V, Tiffany A, Polanek M, Harley BAC. DONOR VARIABILITY IN HUMAN MESENCHYMAL STEM CELL OSTEOGENIC RESPONSE AS A FUNCTION OF PASSAGE CONDITIONS AND DONOR SEX. bioRxiv. 2023.

Kolli S, Bojic S, Ghareeb AE, Kurzawa-Akanbi M, Figueiredo FC, Lako M. The Role of Nerve Growth Factor in Maintaining Proliferative Capacity, Colony-Forming Efficiency, and the Limbal Stem Cell Phenotype. Stem Cells. 2019;37(1):139-149.

Kolken HMA, A Garcia F, A Plessis D, Rans C, Mirzaali MJ, Zadpoor AA. Fatigue performance of auxetic meta-biomaterials. Acta Biomater. 2021.

Kolic J, Sun WQGrace, Cen HHoward, Ewald J, Rogalski JC, Sasaki S, Sun H, Rajesh V, Xia YHan, Moravcova R, et al. Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease. medRxiv. 2024.

Kolev VN, Wright QG, Vidal CM, Ring JE, Shapiro IM, Ricono J, Weaver DT, Padval MV, Pachter JA, Xu Q. PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. Cancer Res. 2014.

Kolesnichenko OA, Whitsett JA, Kalin TV, Kalinichenko VV. Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases. Am J Respir Cell Mol Biol. 2021.

Pages